ProQR
PRQR
#8387
Rank
HK$1.71 B
Marketcap
HK$16.27
Share price
-1.42%
Change (1 day)
-40.96%
Change (1 year)

P/E ratio for ProQR (PRQR)

P/E ratio as of December 2025 (TTM): -4.33

According to ProQR's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.32729. At the end of 2021 the company had a P/E ratio of -7.11.

P/E ratio history for ProQR from 2014 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2021-7.1180.65%
2020-3.93-39.66%
2019-6.52-47.85%
2018-12.5667.21%
2017-1.63-38.14%
2016-2.63-70.04%
2015-8.79-55.99%
2014-20.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Atara Biotherapeutics
ATRA
-37.3 762.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Actinium Pharmaceuticals
ATNM
-0.9561-77.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-1.28-70.35%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.